Form 4 Tracker
Christopher Gibson

Director · 14 filings · Latest: Jun 5, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Christopher GibsonDirectorFeb 19, 2026
Sale
$3.4640,000$138.4K906,556
RXRX
Gibson Christopher—Feb 19, 2026
Proposed Sale
$3.4640,000$138.4K—
RXRX
Christopher GibsonDirectorFeb 4, 2026
Sale
$4.1240,000$164.8K913,839
RXRX
Gibson Christopher—Feb 4, 2026
Proposed Sale
$4.1240,000$164.8K—
RXRX
Christopher GibsonDirectorJan 20, 2026
Sale
$4.4740,000$178.8K913,839
RXRX
Gibson Christopher—Jan 20, 2026
Proposed Sale
$4.4740,000$178.8K—
RXRX
Gibson Christopher—Jan 5, 2026
Proposed Sale
$4.2540,000$170.0K—
RXRX
Gibson Christopher—Dec 19, 2025
Proposed Sale
$4.5040,000$180.0K—
RXRX
Gibson Christopher—Dec 4, 2025
Proposed Sale
$4.6340,000$185.2K—
RXRX
Gibson Christopher—Nov 19, 2025
Proposed Sale
$4.1640,000$166.4K—
RXRX
Gibson Christopher—Nov 4, 2025
Proposed Sale
$5.2140,000$208.4K—
RXRX
Gibson Christopher—Oct 23, 2025
Proposed Sale
$5.70100,000$570.0K—
RXRX
Gibson Christopher—Oct 10, 2025
Proposed Sale
$6.04100,000$604.0K—
RXRX
Gibson Christopher—Sep 25, 2025
Proposed Sale
$4.76100,000$476.0K—
RXRX
Gibson Christopher—Sep 10, 2025
Proposed Sale
$4.71100,000$471.0K—
RXRX
Gibson Christopher—Aug 26, 2025
Proposed Sale
$4.84100,000$484.0K—
RXRX
Gibson Christopher—Aug 11, 2025
Proposed Sale
$5.28617,875$3.3M—
RXRX
Gibson Christopher—Mar 27, 2025
Proposed Sale
$6.04138,574$837.0K—
RXRX
Gibson Christopher—Mar 6, 2025
Proposed Sale
$6.3720,000$127.4K—
RXRX
Gibson Christopher—Mar 5, 2025
Proposed Sale
$6.5820,000$131.6K—